Neurocrine Biosciences Net Profit Margin 2006-2020 | NBIX

Current and historical net profit margin for Neurocrine Biosciences (NBIX) from 2006 to 2020. Net profit margin can be defined as net Income as a portion of total sales revenue. Neurocrine Biosciences net profit margin for the three months ending September 30, 2020 was .
Neurocrine Biosciences Net Profit Margin Historical Data
Date TTM Revenue TTM Net Income Net Margin
2020-09-30 $1.04B $0.09B 8.93%
2020-06-30 $1.01B $0.21B 20.40%
2020-03-31 $0.89B $0.18B 19.84%
2019-12-31 $0.79B $0.04B 4.70%
2019-09-30 $0.68B $0.02B 3.11%
2019-06-30 $0.61B $0.02B 2.98%
2019-03-31 $0.52B $-0.04B -7.53%
2018-12-31 $0.45B $0.02B 4.66%
2018-09-30 $0.42B $0.01B 2.41%
2018-06-30 $0.32B $-0.05B -16.05%
2018-03-31 $0.23B $-0.11B -45.49%
2013-12-31 $0.00B $-0.05B -1150.00%
2013-09-30 $0.03B $-0.03B -104.00%
2013-06-30 $0.03B $-0.02B -54.55%
2013-03-31 $0.04B $-0.01B -16.28%
2012-12-31 $0.05B $0.00B 7.55%
2012-09-30 $0.04B $-0.00B -9.52%
2012-06-30 $0.08B $0.03B 40.00%
2012-03-31 $0.08B $0.03B 43.42%
2011-12-31 $0.08B $0.04B 47.44%
2011-09-30 $0.08B $0.04B 46.91%
2011-06-30 $0.05B $0.01B 18.87%
2011-03-31 $0.05B $0.00B 6.52%
2010-12-31 $0.03B $-0.01B -26.47%
2010-09-30 $0.02B $-0.02B -90.48%
2010-06-30 $0.01B $-0.03B -375.00%
2010-03-31 $0.00B $-0.04B -1000.00%
2009-12-31 $0.00B $-0.05B -1275.00%
2009-09-30 $0.00B $-0.07B -1800.00%
2009-06-30 $0.00B $-0.08B -2050.00%
2009-03-31 $0.00B $-0.09B -2200.00%
2008-12-31 $0.01B $-0.09B -1780.00%
2008-09-30 $0.01B $-0.19B -3760.00%
2008-06-30 $0.01B $-0.20B -3940.00%
2008-03-31 $0.00B $-0.20B -5050.00%
2007-12-31 $0.00B $-0.21B -10350.00%
2007-09-30 $0.01B $-0.09B -940.00%
2007-06-30 $0.01B $-0.11B -1060.00%
2007-03-31 $0.02B $-0.11B -563.16%
2006-12-31 $0.04B $-0.11B -281.58%
2006-09-30 $0.04B $-0.12B -269.77%
2006-06-30 $0.11B $-0.05B -47.66%
2006-03-31 $0.13B $-0.03B -22.90%
2005-12-31 $0.12B $-0.02B -18.55%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $8.747B $0.788B
Neurocrine Biosciences is a neuroscience-based company focused on the discovery and development of novel therapeutics for neuropsychiatric, neuroinflammatory and neurodegenerative diseases and disorders. The company's neuroscience, endocrine and immunology disciplines provide a unique biological understanding of the molecular interaction between central nervous, immune and endocrine systems for the development of therapeutic interventions for anxiety, depression, insomnia, stroke, malignant brain tumors, multiple sclerosis, obesity and diabetes.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $78.106B 42.58
Takeda Pharmaceutical (TAK) Japan $55.520B 10.36
Astellas Pharma (ALPMY) Japan $28.616B 17.87
Eisai (ESALY) Japan $22.188B 19.33
UCB SA (UCBJF) Belgium $21.755B 0.00
Merck (MKGAF) Germany $19.910B 26.11
Catalent (CTLT) United States $16.437B 49.16
Grifols, S.A (GRFS) Spain $12.830B 14.69
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $11.500B 23.81
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $8.401B 0.00
IPSEN SA ADR (IPSEY) France $8.227B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $8.040B 12.99
Ionis Pharmaceuticals (IONS) United States $7.029B 68.86
Arrowhead Pharmaceuticals (ARWR) United States $6.976B 0.00
STADA ARZNEIMI (STDAF) Germany $6.884B 0.00
Orion OYJ (ORINY) Finland $6.272B 21.76
United Therapeutics (UTHR) United States $6.123B 13.03
Evotec AG (EVTCY) Germany $4.852B 329.72
PTC Therapeutics (PTCT) United States $4.247B 0.00
Sage Therapeutics (SAGE) United States $4.058B 0.00
ChemoCentryx (CCXI) United States $3.964B 0.00
FibroGen (FGEN) United States $3.658B 0.00
Hypermarcas (HYPMY) Brazil $3.509B 12.91
Nektar Therapeutics (NKTR) United States $2.965B 0.00
Pacira BioSciences (PCRX) United States $2.777B 60.30
Revolution Medicines (RVMD) United States $2.705B 0.00
Corcept Therapeutics (CORT) United States $2.672B 25.84
Cronos Group (CRON) Canada $2.614B 0.00
Taro Pharmaceutical Industries (TARO) Israel $2.557B 13.05
Xencor (XNCR) United States $2.350B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.920B 16.42
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.763B 0.00
Trillium Therapeutics (TRIL) Canada $1.733B 0.00
Heron Therapeutics (HRTX) United States $1.641B 0.00
USANA Health Sciences (USNA) United States $1.600B 14.08
Translate Bio (TBIO) United States $1.356B 0.00
Indivior (INVVY) United States $1.279B 15.85
Endo (ENDP) Ireland $1.239B 1.88
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.226B 8.52
Zogenix (ZGNX) United States $1.158B 0.00
Karyopharm Therapeutics (KPTI) United States $1.115B 0.00
Ocular Therapeutix (OCUL) United States $1.070B 0.00
ImmunoGen (IMGN) United States $1.065B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.038B 0.00
CLINIGEN GP (CLIGF) United Kingdom $0.942B 0.00
Vectura Group (VEGPF) United Kingdom $0.925B 0.00
Tilray (TLRY) Canada $0.892B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.877B 0.00
VAXART, INC (VXRT) United States $0.779B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.777B 0.00
Calliditas Therapeutics AB (CALT) Sweden $0.773B 0.00
Esperion Therapeutics (ESPR) United States $0.762B 0.00
Radius Health (RDUS) United States $0.745B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.650B 33.88
Spectrum Pharmaceuticals (SPPI) United States $0.636B 0.00
Collegium Pharmaceutical (COLL) United States $0.634B 37.39
Chinook Therapeutics (KDNY) United States $0.575B 0.00
Aerie Pharmaceuticals (AERI) United States $0.574B 0.00
Siga Technologies (SIGA) United States $0.559B 15.70
Organogenesis Holdings (ORGO) United States $0.557B 0.00
Flexion Therapeutics (FLXN) United States $0.542B 0.00
Ardelyx (ARDX) United States $0.535B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.483B 0.00
Molecular Templates (MTEM) United States $0.450B 0.00
Akebia Therapeutics (AKBA) United States $0.444B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.427B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.416B 0.00
Innate Pharma SA (IPHYF) France $0.396B 0.00
TherapeuticsMD (TXMD) United States $0.382B 0.00
Harpoon Therapeutics (HARP) United States $0.370B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.357B 9.30
Calithera Biosciences (CALA) United States $0.350B 0.00
DURECT (DRRX) United States $0.349B 0.00
Profound Medical (PROF) Canada $0.349B 0.00
Concert Pharmaceuticals (CNCE) United States $0.334B 0.00
Redhill Biopharma (RDHL) Israel $0.329B 0.00
KalVista Pharmaceuticals (KALV) United States $0.327B 0.00
Rafael Holdings (RFL) United States $0.321B 0.00
MEI Pharma (MEIP) United States $0.316B 0.00
Altimmune (ALT) United States $0.306B 0.00
Summit Therapeutics (SMMT) United States $0.296B 0.00
CTI BioPharma (CTIC) United States $0.280B 0.00
CASI Pharmaceuticals (CASI) United States $0.279B 0.00
Menlo Therapeutics (VYNE) United States $0.275B 0.00
Jounce Therapeutics (JNCE) United States $0.272B 0.00
Lannett Co Inc (LCI) United States $0.256B 6.76
Nature's Sunshine Products (NATR) United States $0.249B 16.04
IMV INC (IMV) Canada $0.236B 0.00
Aquestive Therapeutics (AQST) United States $0.228B 0.00
OptiNose (OPTN) United States $0.227B 0.00
Xeris Pharmaceuticals (XERS) United States $0.219B 0.00
Otonomy (OTIC) United States $0.212B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.208B 0.00
Alpine Immune Sciences (ALPN) United States $0.184B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.172B 0.00
Heat Biologics (HTBX) United States $0.160B 0.00
Taiwan Liposome (TLC) Taiwan $0.160B 0.00
Champions Oncology (CSBR) United States $0.158B 0.00
Aclaris Therapeutics (ACRS) United States $0.134B 0.00
Infinity Pharmaceuticals (INFI) United States $0.132B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.132B 0.00
Ayala Pharmaceuticals (AYLA) Israel $0.132B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.130B 0.00
Lipocine (LPCN) United States $0.104B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.103B 0.00
MediWound (MDWD) Israel $0.100B 0.00
ProPhase Labs (PRPH) United States $0.088B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.084B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.080B 0.00
Biomerica (BMRA) United States $0.078B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.078B 0.00
KemPharm (KMPH) United States $0.077B 0.00
Nutriband (NTRB) United States $0.071B 0.00
Hemispherx BioPharma (AIM) United States $0.070B 0.00
ElectroCore (ECOR) United States $0.070B 0.00
Novan (NOVN) United States $0.068B 0.00
AgeX Therapeutics (AGE) United States $0.067B 0.00
Natural Alternatives (NAII) United States $0.067B 128.62
SCYNEXIS (SCYX) United States $0.065B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.064B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.063B 0.00
India Globalization Capital (IGC) United States $0.061B 0.00
Addex Therapeutics (ADXN) Switzerland $0.061B 0.00
GTx (ONCT) United States $0.058B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.053B 0.00
Onconova Therapeutics (ONTX) United States $0.049B 0.00
Recro Pharma (REPH) United States $0.048B 0.00
Forward Pharma (FWP) Denmark $0.047B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.047B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.045B 22.77
Adamis Pharmaceuticals (ADMP) United States $0.037B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.037B 0.00
Mannatechorporated (MTEX) United States $0.035B 5.20
Vical (BBI) United States $0.033B 0.00
IsoRay (ISR) United States $0.032B 0.00
Neos Therapeutics (NEOS) United States $0.028B 0.00
Can-Fite Biopharma (CANF) Israel $0.028B 0.00
PolarityTE (PTE) United States $0.026B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.026B 0.00
Sundial Growers (SNDL) Canada $0.026B 0.00
Iterum Therapeutics (ITRM) Ireland $0.025B 0.00
Regulus Therapeutics (RGLS) United States $0.025B 0.00
Midatech Pharma (MTP) United Kingdom $0.023B 0.00
Hancock Jaffe Laboratories (HJLI) United States $0.019B 0.00
Jaguar Animal Health (JAGX) United States $0.017B 0.00
Bio-Path Holdings (BPTH) United States $0.016B 0.00
Cyanotech (CYAN) United States $0.016B 25.50
Eyegate Pharmaceuticals (EYEG) United States $0.016B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.015B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.015B 0.00
Flex Pharma (SLRX) United States $0.013B 0.00
RXi Pharmaceuticals (PHIO) United States $0.013B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.010B 0.00
China SXT Pharmaceuticals (SXTC) China $0.010B 0.00
Shineco (TYHT) China $0.009B 0.00
JanOne (JAN) United States $0.008B 0.00
Xenetic Biosciences (XBIO) United States $0.005B 0.00
CannTrust Holdings (CTST) Canada $0.000B 0.00